Vitamin D Compounds PRI-2191 and PRI-2205 Enhance Anastrozole Activity in Human Breast Cancer Models
1,25-Dihydroxycholecalciferol, the hormonally active vitamin D<sub>3</sub> metabolite, is known to exhibit therapeutic effects against breast cancer, mainly by lowering the expression of estrogen receptors and aromatase activity. Previously, the safety of the vitamin D active metabolite...
Main Authors: | Beata Filip-Psurska, Mateusz Psurski, Artur Anisiewicz, Patrycja Libako, Ewa Zbrojewicz, Magdalena Maciejewska, Michał Chodyński, Andrzej Kutner, Joanna Wietrzyk |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/5/2781 |
Similar Items
-
The effect of anastrozol on spatial memory in adult rats
by: Hodosy Július, et al.
Published: (2009-06-01) -
Rethinking the combination treatment of fulvestrant and anastrozole for metastatic breast cancer: an integrated reanalysis of aromatase–estrogen receptor axis
by: Xing Huang
Published: (2019-11-01) -
Anastrozole-Induced Dermatitis: Report of a Woman with an Anastrozole-Associated Dermatosis and a Review of Aromatase Inhibitor-Related Cutaneous Adverse Events
by: Yoo Jung Kim, et al.
Published: (2020-01-01) -
Oral lichen sclerosus in a breast cancer patient on anastrozole therapy: A case report with brief review of literature
by: Chaturbhuj Agrawal, et al.
Published: (2017-01-01) -
Palliative treatment of endometrial cancer: what is the role of anastrozole in elderly women?
by: Barbara Gardella, et al.
Published: (2021-02-01)